| 2.6 |
10.5 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.5 |
6.1 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 1.5 |
19.5 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 1.5 |
4.5 |
GO:1904603 |
regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 1.4 |
5.6 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 1.3 |
5.3 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 1.2 |
6.2 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 1.2 |
7.3 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 1.2 |
2.4 |
GO:0043465 |
fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 1.2 |
1.2 |
GO:0006714 |
sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 1.2 |
3.5 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 1.1 |
1.1 |
GO:0061517 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
| 1.0 |
1.0 |
GO:0072104 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 1.0 |
6.3 |
GO:0070295 |
renal water absorption(GO:0070295) |
| 1.0 |
1.0 |
GO:0036023 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 1.0 |
3.0 |
GO:1904204 |
regulation of skeletal muscle hypertrophy(GO:1904204) |
| 1.0 |
3.0 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 1.0 |
6.0 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 1.0 |
5.9 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 1.0 |
2.9 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 1.0 |
6.8 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.9 |
3.7 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.9 |
3.7 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.9 |
3.6 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.9 |
2.7 |
GO:0035759 |
mesangial cell-matrix adhesion(GO:0035759) |
| 0.9 |
4.4 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.9 |
6.1 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.9 |
3.5 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.9 |
2.6 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.9 |
1.7 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 0.8 |
6.7 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.8 |
5.8 |
GO:0030421 |
defecation(GO:0030421) |
| 0.8 |
9.1 |
GO:0090500 |
endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.8 |
137.8 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.8 |
2.4 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.8 |
3.2 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.8 |
3.1 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.8 |
2.3 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.8 |
3.0 |
GO:0032599 |
B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 0.8 |
5.3 |
GO:0036018 |
cellular response to erythropoietin(GO:0036018) |
| 0.8 |
0.8 |
GO:0014734 |
skeletal muscle hypertrophy(GO:0014734) |
| 0.8 |
4.5 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.8 |
8.3 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.7 |
2.9 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.7 |
5.1 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.7 |
2.9 |
GO:1902378 |
vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.7 |
2.1 |
GO:0002415 |
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.7 |
2.1 |
GO:0060739 |
mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
| 0.7 |
0.7 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.7 |
4.1 |
GO:0035105 |
sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.7 |
2.0 |
GO:0031104 |
dendrite regeneration(GO:0031104) |
| 0.7 |
0.7 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.7 |
6.0 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.7 |
6.0 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.7 |
4.6 |
GO:0086100 |
endothelin receptor signaling pathway(GO:0086100) |
| 0.6 |
4.5 |
GO:0097017 |
renal protein absorption(GO:0097017) |
| 0.6 |
2.6 |
GO:0009956 |
radial pattern formation(GO:0009956) |
| 0.6 |
1.9 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.6 |
3.2 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.6 |
3.8 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.6 |
1.3 |
GO:0010868 |
negative regulation of triglyceride biosynthetic process(GO:0010868) |
| 0.6 |
2.5 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.6 |
3.1 |
GO:1902228 |
mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.6 |
3.1 |
GO:0001969 |
activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
| 0.6 |
2.4 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.6 |
1.2 |
GO:0010645 |
regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.6 |
1.8 |
GO:0051041 |
positive regulation of calcium-independent cell-cell adhesion(GO:0051041) |
| 0.6 |
1.8 |
GO:0010877 |
lipid transport involved in lipid storage(GO:0010877) |
| 0.6 |
2.3 |
GO:0032223 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.6 |
3.5 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.6 |
1.7 |
GO:0032771 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.6 |
1.1 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.6 |
4.0 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.6 |
2.3 |
GO:0060448 |
dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.6 |
0.6 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.6 |
5.6 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.6 |
0.6 |
GO:0002730 |
regulation of dendritic cell cytokine production(GO:0002730) |
| 0.6 |
6.1 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.5 |
12.1 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.5 |
1.6 |
GO:2001035 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.5 |
2.2 |
GO:0010983 |
positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.5 |
7.1 |
GO:1903142 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.5 |
3.3 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.5 |
2.2 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.5 |
5.9 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.5 |
1.1 |
GO:0070662 |
mast cell proliferation(GO:0070662) |
| 0.5 |
0.5 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.5 |
2.1 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.5 |
1.6 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 0.5 |
1.6 |
GO:0042662 |
negative regulation of mesodermal cell fate specification(GO:0042662) |
| 0.5 |
2.1 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.5 |
9.8 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.5 |
2.6 |
GO:0072276 |
metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
| 0.5 |
0.5 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.5 |
2.1 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.5 |
0.5 |
GO:0003165 |
Purkinje myocyte development(GO:0003165) |
| 0.5 |
1.0 |
GO:0072244 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.5 |
2.5 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.5 |
1.5 |
GO:1904237 |
regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 0.5 |
0.5 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.5 |
2.0 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.5 |
2.0 |
GO:0086097 |
phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.5 |
2.5 |
GO:0042222 |
interleukin-1 biosynthetic process(GO:0042222) |
| 0.5 |
1.5 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 0.5 |
4.4 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.5 |
2.9 |
GO:0009753 |
response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.5 |
1.4 |
GO:1905237 |
response to cyclosporin A(GO:1905237) |
| 0.5 |
1.4 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.5 |
1.4 |
GO:0042489 |
negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.5 |
1.9 |
GO:0036229 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.5 |
1.4 |
GO:1903414 |
regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.5 |
2.3 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.5 |
4.2 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.5 |
0.9 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.5 |
2.7 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
| 0.4 |
3.1 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.4 |
1.8 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.4 |
2.6 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.4 |
1.3 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.4 |
9.0 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.4 |
1.7 |
GO:1900228 |
biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.4 |
4.6 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.4 |
1.3 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.4 |
2.1 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.4 |
1.2 |
GO:0051821 |
negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010768) transmission of virus(GO:0019089) dissemination or transmission of symbiont from host(GO:0044007) dissemination or transmission of organism from other organism involved in symbiotic interaction(GO:0051821) |
| 0.4 |
3.3 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 0.4 |
1.2 |
GO:1903413 |
cellular response to bile acid(GO:1903413) |
| 0.4 |
1.2 |
GO:0019442 |
tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.4 |
2.0 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.4 |
1.2 |
GO:1901876 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.4 |
6.4 |
GO:1900746 |
regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
| 0.4 |
0.4 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.4 |
4.3 |
GO:0033123 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.4 |
2.3 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.4 |
1.2 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.4 |
4.3 |
GO:0038089 |
positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.4 |
3.1 |
GO:0060029 |
convergent extension involved in organogenesis(GO:0060029) |
| 0.4 |
1.5 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 0.4 |
1.9 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.4 |
3.0 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.4 |
1.9 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.4 |
1.1 |
GO:0042946 |
glucoside transport(GO:0042946) glycoside transport(GO:1901656) |
| 0.4 |
0.4 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.4 |
0.7 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.4 |
1.5 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.4 |
1.8 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.4 |
2.6 |
GO:0072719 |
cellular response to cisplatin(GO:0072719) |
| 0.4 |
3.3 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.4 |
2.9 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.4 |
1.4 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.3 |
1.0 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.3 |
2.4 |
GO:0060356 |
leucine import(GO:0060356) |
| 0.3 |
1.4 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.3 |
1.7 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.3 |
1.0 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.3 |
1.0 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.3 |
2.7 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.3 |
3.3 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.3 |
1.3 |
GO:0021538 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.3 |
0.3 |
GO:0045645 |
regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.3 |
1.3 |
GO:1903400 |
L-arginine transmembrane transport(GO:1903400) |
| 0.3 |
1.0 |
GO:1990764 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.3 |
1.0 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.3 |
1.7 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.3 |
2.3 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.3 |
0.3 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.3 |
1.6 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 0.3 |
0.7 |
GO:0060434 |
bronchus morphogenesis(GO:0060434) |
| 0.3 |
2.3 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.3 |
1.9 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.3 |
0.3 |
GO:0042668 |
auditory receptor cell fate determination(GO:0042668) |
| 0.3 |
0.3 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.3 |
1.0 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.3 |
1.6 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.3 |
1.0 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.3 |
2.9 |
GO:0090191 |
negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.3 |
1.9 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.3 |
7.6 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.3 |
0.3 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 |
1.3 |
GO:0010728 |
regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.3 |
6.9 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.3 |
0.6 |
GO:0060940 |
epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.3 |
0.9 |
GO:0038158 |
granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
| 0.3 |
0.9 |
GO:0071799 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.3 |
0.6 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.3 |
1.2 |
GO:0071231 |
cellular response to folic acid(GO:0071231) |
| 0.3 |
0.6 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.3 |
2.4 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.3 |
0.9 |
GO:0042695 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.3 |
0.9 |
GO:0098506 |
nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) DNA 3' dephosphorylation(GO:0098503) DNA 3' dephosphorylation involved in DNA repair(GO:0098504) polynucleotide 3' dephosphorylation(GO:0098506) |
| 0.3 |
1.2 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.3 |
0.9 |
GO:0035573 |
N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.3 |
0.9 |
GO:2000296 |
negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.3 |
0.9 |
GO:0060827 |
regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.3 |
1.7 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.3 |
2.9 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.3 |
0.9 |
GO:1904199 |
positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 0.3 |
2.6 |
GO:0097490 |
sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.3 |
1.1 |
GO:1903892 |
negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
| 0.3 |
0.8 |
GO:0046707 |
IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.3 |
0.3 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.3 |
2.0 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.3 |
2.5 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.3 |
1.4 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.3 |
3.3 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.3 |
0.3 |
GO:0042427 |
serotonin biosynthetic process(GO:0042427) |
| 0.3 |
2.5 |
GO:0031999 |
negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 0.3 |
0.8 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.3 |
1.4 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.3 |
0.8 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.3 |
0.8 |
GO:0021938 |
ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 0.3 |
0.8 |
GO:0045062 |
extrathymic T cell selection(GO:0045062) |
| 0.3 |
1.1 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.3 |
1.9 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.3 |
0.8 |
GO:0036323 |
vascular endothelial growth factor receptor-1 signaling pathway(GO:0036323) |
| 0.3 |
1.6 |
GO:0060620 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.3 |
0.5 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.3 |
1.6 |
GO:0050666 |
regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.3 |
2.4 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.3 |
1.3 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.3 |
0.8 |
GO:0071810 |
regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.3 |
0.3 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.3 |
0.8 |
GO:2001311 |
lysobisphosphatidic acid metabolic process(GO:2001311) |
| 0.3 |
1.3 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.3 |
5.3 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 0.3 |
1.6 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.3 |
0.8 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 0.3 |
1.3 |
GO:0090210 |
regulation of establishment of blood-brain barrier(GO:0090210) |
| 0.3 |
0.8 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.3 |
3.1 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.3 |
0.8 |
GO:0032824 |
negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.3 |
2.3 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.3 |
0.8 |
GO:0002933 |
lipid hydroxylation(GO:0002933) |
| 0.3 |
0.3 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 0.3 |
5.1 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.3 |
0.5 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.3 |
0.3 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.3 |
1.3 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.3 |
1.8 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
| 0.2 |
0.7 |
GO:0060921 |
sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
| 0.2 |
0.5 |
GO:1903719 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.2 |
5.0 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.2 |
8.2 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.2 |
0.2 |
GO:0060353 |
regulation of cell adhesion molecule production(GO:0060353) |
| 0.2 |
5.0 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.2 |
1.2 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.2 |
0.7 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.2 |
1.0 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.2 |
1.0 |
GO:0090027 |
negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.2 |
0.5 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.2 |
1.0 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.2 |
2.4 |
GO:0007598 |
blood coagulation, extrinsic pathway(GO:0007598) |
| 0.2 |
1.9 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.2 |
1.7 |
GO:0043102 |
amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
| 0.2 |
1.0 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.2 |
0.2 |
GO:0060599 |
lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
| 0.2 |
1.0 |
GO:0005986 |
sucrose biosynthetic process(GO:0005986) |
| 0.2 |
1.0 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.2 |
1.9 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.2 |
1.0 |
GO:2000435 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.2 |
0.7 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 0.2 |
0.2 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.2 |
0.7 |
GO:0045629 |
negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.2 |
1.6 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.2 |
0.5 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.2 |
1.2 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 0.2 |
1.8 |
GO:0060574 |
intestinal epithelial cell maturation(GO:0060574) |
| 0.2 |
0.5 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.2 |
0.9 |
GO:0009224 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.2 |
0.7 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.2 |
2.1 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 |
0.9 |
GO:0014806 |
smooth muscle hyperplasia(GO:0014806) |
| 0.2 |
1.4 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.2 |
6.1 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.2 |
1.6 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.2 |
1.8 |
GO:0050665 |
hydrogen peroxide biosynthetic process(GO:0050665) |
| 0.2 |
0.2 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.2 |
0.2 |
GO:1902949 |
positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.2 |
0.9 |
GO:0044111 |
development involved in symbiotic interaction(GO:0044111) |
| 0.2 |
0.7 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.2 |
2.7 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.2 |
0.7 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.2 |
3.3 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.2 |
0.7 |
GO:0002125 |
maternal aggressive behavior(GO:0002125) |
| 0.2 |
1.3 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.2 |
0.4 |
GO:2000259 |
positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.2 |
0.4 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.2 |
1.7 |
GO:0014827 |
intestine smooth muscle contraction(GO:0014827) |
| 0.2 |
3.9 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 |
0.2 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.2 |
1.3 |
GO:0034164 |
negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.2 |
0.6 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.2 |
1.5 |
GO:0010734 |
protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.2 |
7.5 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.2 |
1.1 |
GO:1901860 |
positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.2 |
1.5 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 |
3.6 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.2 |
0.6 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.2 |
3.0 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.2 |
0.8 |
GO:0033076 |
isoquinoline alkaloid metabolic process(GO:0033076) |
| 0.2 |
1.1 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.2 |
0.8 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.2 |
0.6 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.2 |
1.0 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.2 |
0.4 |
GO:0061047 |
positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.2 |
0.4 |
GO:0097325 |
melanocyte proliferation(GO:0097325) |
| 0.2 |
2.9 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.2 |
1.9 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.2 |
1.4 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 |
0.6 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.2 |
4.1 |
GO:0032966 |
negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.2 |
1.0 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.2 |
1.0 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.2 |
0.8 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.2 |
0.4 |
GO:1990051 |
activation of protein kinase C activity(GO:1990051) |
| 0.2 |
31.8 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.2 |
0.4 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.2 |
0.4 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.2 |
0.6 |
GO:0001189 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.2 |
0.6 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.2 |
0.4 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.2 |
0.6 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.2 |
0.8 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 0.2 |
0.6 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 0.2 |
0.4 |
GO:2001302 |
lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.2 |
1.0 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.2 |
4.5 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.2 |
0.8 |
GO:0009820 |
alkaloid metabolic process(GO:0009820) |
| 0.2 |
0.8 |
GO:2000977 |
regulation of forebrain neuron differentiation(GO:2000977) |
| 0.2 |
0.4 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.2 |
2.3 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.2 |
4.7 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.2 |
0.6 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.2 |
0.8 |
GO:0010193 |
response to ozone(GO:0010193) |
| 0.2 |
1.2 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.2 |
0.8 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.2 |
0.6 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.2 |
3.3 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.2 |
0.8 |
GO:0071348 |
cellular response to interleukin-11(GO:0071348) |
| 0.2 |
1.2 |
GO:0097461 |
ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.2 |
1.1 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.2 |
0.8 |
GO:0033306 |
phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 0.2 |
0.8 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.2 |
11.8 |
GO:0035987 |
endodermal cell differentiation(GO:0035987) |
| 0.2 |
0.8 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.2 |
1.1 |
GO:0070378 |
positive regulation of ERK5 cascade(GO:0070378) |
| 0.2 |
0.9 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 |
0.8 |
GO:0018106 |
peptidyl-histidine phosphorylation(GO:0018106) |
| 0.2 |
0.8 |
GO:0060197 |
cloacal septation(GO:0060197) |
| 0.2 |
4.5 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.2 |
0.6 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.2 |
0.6 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.2 |
0.4 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.2 |
0.7 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.2 |
0.6 |
GO:1904863 |
regulation of beta-catenin-TCF complex assembly(GO:1904863) negative regulation of beta-catenin-TCF complex assembly(GO:1904864) |
| 0.2 |
0.6 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.2 |
2.0 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.2 |
0.5 |
GO:0046333 |
octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
| 0.2 |
1.1 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.2 |
4.4 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.2 |
1.5 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.2 |
3.1 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.2 |
2.4 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.2 |
0.4 |
GO:0010899 |
regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.2 |
1.4 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.2 |
0.9 |
GO:0002414 |
immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.2 |
0.9 |
GO:0097403 |
cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.2 |
3.1 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.2 |
0.5 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.2 |
0.7 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) isoleucine catabolic process(GO:0006550) |
| 0.2 |
0.9 |
GO:0035986 |
senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.2 |
0.7 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.2 |
0.7 |
GO:0010902 |
positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.2 |
1.2 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 |
0.9 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.2 |
4.2 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.2 |
0.2 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.2 |
1.7 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
0.7 |
GO:0044266 |
angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
| 0.2 |
1.0 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.2 |
1.4 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.2 |
0.9 |
GO:0034239 |
macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
| 0.2 |
1.0 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.2 |
1.5 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 |
4.9 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.2 |
1.5 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.2 |
0.5 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.2 |
0.5 |
GO:0086048 |
membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.2 |
0.5 |
GO:0045425 |
regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
| 0.2 |
6.8 |
GO:0060706 |
cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.2 |
2.7 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 |
4.5 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.2 |
0.5 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.2 |
0.5 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.2 |
3.3 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.2 |
0.2 |
GO:0018262 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.2 |
0.7 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.2 |
0.7 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.2 |
0.8 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.2 |
0.5 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.2 |
0.3 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.2 |
0.7 |
GO:1903936 |
cellular response to sodium arsenite(GO:1903936) |
| 0.2 |
0.3 |
GO:0001507 |
acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.2 |
0.2 |
GO:0002176 |
male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.2 |
0.8 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.2 |
0.5 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.2 |
0.6 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.2 |
0.3 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.2 |
1.6 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.2 |
0.8 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.2 |
4.2 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.2 |
0.5 |
GO:0060936 |
cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
| 0.2 |
1.3 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.2 |
0.8 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.2 |
1.4 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.2 |
1.1 |
GO:0048743 |
positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.2 |
0.2 |
GO:1904732 |
regulation of electron carrier activity(GO:1904732) |
| 0.2 |
0.5 |
GO:0035771 |
interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.2 |
0.8 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.2 |
0.5 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 |
2.5 |
GO:0098743 |
cell aggregation(GO:0098743) |
| 0.2 |
2.2 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.2 |
1.3 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.2 |
2.2 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.2 |
0.5 |
GO:0035915 |
pore formation in membrane of other organism(GO:0035915) |
| 0.2 |
1.4 |
GO:0098868 |
bone growth(GO:0098868) |
| 0.2 |
0.5 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.2 |
0.2 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.2 |
2.1 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.2 |
1.7 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.2 |
0.8 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.2 |
0.8 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 |
0.5 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.2 |
0.8 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.1 |
GO:0009946 |
proximal/distal axis specification(GO:0009946) |
| 0.1 |
0.6 |
GO:1905225 |
response to thyrotropin-releasing hormone(GO:1905225) |
| 0.1 |
0.4 |
GO:0050928 |
negative regulation of positive chemotaxis(GO:0050928) |
| 0.1 |
0.7 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 |
0.7 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 |
0.7 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.1 |
1.5 |
GO:0042424 |
catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.1 |
3.8 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
1.9 |
GO:0035791 |
platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.1 |
2.2 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.1 |
0.4 |
GO:0060721 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.1 |
0.1 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.1 |
0.3 |
GO:0070244 |
negative regulation of thymocyte apoptotic process(GO:0070244) |
| 0.1 |
0.9 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 |
0.3 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.1 |
0.3 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
0.7 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.1 |
0.6 |
GO:0032429 |
regulation of phospholipase A2 activity(GO:0032429) |
| 0.1 |
0.9 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.1 |
0.1 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.1 |
0.4 |
GO:0008354 |
germ cell migration(GO:0008354) |
| 0.1 |
0.3 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.1 |
1.5 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.4 |
GO:0009698 |
phenylpropanoid metabolic process(GO:0009698) |
| 0.1 |
1.1 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
8.0 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.1 |
0.8 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 |
0.8 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
0.4 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 |
1.0 |
GO:0090094 |
metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.1 |
0.3 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.1 |
0.7 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
0.7 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.1 |
1.4 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.1 |
0.7 |
GO:1902462 |
mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 |
1.0 |
GO:0086029 |
Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.1 |
1.2 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.1 |
1.1 |
GO:1904179 |
regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
| 0.1 |
0.7 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
0.1 |
GO:0003344 |
pericardium morphogenesis(GO:0003344) |
| 0.1 |
0.8 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
1.0 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.1 |
2.7 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 |
4.5 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.1 |
0.8 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.1 |
0.7 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
0.5 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.1 |
1.6 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.1 |
1.2 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.1 |
0.3 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.1 |
0.3 |
GO:0032803 |
regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.1 |
0.1 |
GO:1900154 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 |
0.4 |
GO:0061402 |
cellular response to potassium ion starvation(GO:0051365) positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
| 0.1 |
1.3 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.1 |
3.3 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.1 |
2.1 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 |
0.5 |
GO:0031455 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.1 |
0.3 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 |
0.3 |
GO:0098904 |
regulation of AV node cell action potential(GO:0098904) |
| 0.1 |
0.9 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.1 |
0.4 |
GO:0034443 |
negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.1 |
0.1 |
GO:0048550 |
negative regulation of pinocytosis(GO:0048550) |
| 0.1 |
1.3 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.1 |
0.4 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.1 |
24.5 |
GO:0002377 |
immunoglobulin production(GO:0002377) |
| 0.1 |
2.3 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.1 |
1.2 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.1 |
0.4 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.1 |
2.1 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.1 |
0.3 |
GO:0002266 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.1 |
0.5 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.1 |
1.0 |
GO:0010616 |
negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of lung blood pressure(GO:0061767) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.1 |
1.0 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.1 |
2.0 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.3 |
GO:0015911 |
plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.1 |
0.1 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) |
| 0.1 |
3.1 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
0.5 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
1.1 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
1.8 |
GO:0002138 |
retinoic acid biosynthetic process(GO:0002138) |
| 0.1 |
0.4 |
GO:0038001 |
paracrine signaling(GO:0038001) |
| 0.1 |
1.6 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.1 |
0.1 |
GO:0060139 |
positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.1 |
0.4 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.1 |
6.9 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.1 |
0.6 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.1 |
2.2 |
GO:1901748 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 |
0.4 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 |
2.7 |
GO:0033275 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 |
0.7 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 |
0.5 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.1 |
1.3 |
GO:0070862 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
0.4 |
GO:1903595 |
positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.1 |
1.1 |
GO:0030947 |
regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.1 |
0.5 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.1 |
0.7 |
GO:0060026 |
convergent extension(GO:0060026) |
| 0.1 |
1.4 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.1 |
1.5 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.1 |
1.1 |
GO:0052697 |
flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.1 |
3.3 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.1 |
1.9 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 |
0.2 |
GO:1990641 |
response to iron ion starvation(GO:1990641) |
| 0.1 |
0.2 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.1 |
0.6 |
GO:0007571 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.1 |
0.3 |
GO:0035445 |
borate transmembrane transport(GO:0035445) borate transport(GO:0046713) |
| 0.1 |
0.3 |
GO:1900127 |
positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.1 |
3.4 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
0.5 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 |
0.3 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.1 |
0.2 |
GO:0007518 |
myoblast fate determination(GO:0007518) |
| 0.1 |
0.1 |
GO:0034435 |
steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.1 |
0.3 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.1 |
3.1 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.1 |
0.7 |
GO:0016093 |
polyprenol metabolic process(GO:0016093) |
| 0.1 |
1.1 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.1 |
0.1 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.1 |
0.1 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
0.8 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 |
0.8 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.1 |
0.8 |
GO:0010814 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 |
2.4 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
3.1 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
0.9 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.8 |
GO:0035934 |
corticosterone secretion(GO:0035934) |
| 0.1 |
0.5 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
4.5 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.1 |
1.5 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.1 |
0.2 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.1 |
2.1 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.1 |
1.6 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.1 |
3.4 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.1 |
0.1 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.1 |
1.1 |
GO:0018231 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.4 |
GO:1900276 |
regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.1 |
0.6 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.1 |
0.3 |
GO:0014745 |
negative regulation of muscle adaptation(GO:0014745) |
| 0.1 |
1.0 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 |
0.4 |
GO:1901318 |
negative regulation of sperm motility(GO:1901318) |
| 0.1 |
0.6 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.1 |
0.1 |
GO:0060676 |
ureteric bud formation(GO:0060676) |
| 0.1 |
0.4 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 |
0.5 |
GO:0046778 |
modification by virus of host mRNA processing(GO:0046778) |
| 0.1 |
0.4 |
GO:0001835 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.1 |
0.2 |
GO:0019530 |
taurine metabolic process(GO:0019530) |
| 0.1 |
0.5 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 |
0.5 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
| 0.1 |
0.3 |
GO:0060730 |
regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.1 |
4.8 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 |
0.2 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.1 |
1.0 |
GO:0048569 |
post-embryonic organ development(GO:0048569) |
| 0.1 |
0.6 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
1.1 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.1 |
1.2 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.1 |
2.0 |
GO:0071025 |
RNA surveillance(GO:0071025) |
| 0.1 |
0.4 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.1 |
3.8 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.1 |
0.2 |
GO:0006311 |
meiotic gene conversion(GO:0006311) |
| 0.1 |
0.4 |
GO:0072011 |
glomerular endothelium development(GO:0072011) |
| 0.1 |
1.3 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.1 |
0.9 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
1.4 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.3 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.1 |
0.4 |
GO:0001777 |
T cell homeostatic proliferation(GO:0001777) |
| 0.1 |
1.8 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 |
0.3 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.1 |
1.7 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.1 |
0.3 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
0.3 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.1 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.1 |
1.3 |
GO:0014894 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 |
1.0 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 |
0.4 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.1 |
0.7 |
GO:0006707 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
0.5 |
GO:0033512 |
L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 |
0.5 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.1 |
1.4 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.1 |
0.6 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.1 |
1.8 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
3.3 |
GO:0048012 |
hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.1 |
0.6 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.1 |
0.4 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.1 |
4.1 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.1 |
0.2 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.1 |
2.3 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
| 0.1 |
0.3 |
GO:0035993 |
deltoid tuberosity development(GO:0035993) |
| 0.1 |
2.0 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
0.4 |
GO:2000209 |
regulation of anoikis(GO:2000209) |
| 0.1 |
0.4 |
GO:0033590 |
response to cobalamin(GO:0033590) |
| 0.1 |
1.2 |
GO:0048730 |
epidermis morphogenesis(GO:0048730) |
| 0.1 |
0.3 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.1 |
0.5 |
GO:0030961 |
peptidyl-arginine hydroxylation(GO:0030961) |
| 0.1 |
1.2 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 |
0.5 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.1 |
0.3 |
GO:0036363 |
transforming growth factor beta activation(GO:0036363) |
| 0.1 |
0.8 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) |
| 0.1 |
2.5 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.1 |
1.0 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.1 |
1.5 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
0.3 |
GO:0042488 |
positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
| 0.1 |
0.1 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
1.1 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.1 |
0.4 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.1 |
1.0 |
GO:0032057 |
negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.1 |
0.3 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.1 |
1.4 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.2 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.1 |
0.4 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 |
0.9 |
GO:0097398 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 |
0.2 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
0.4 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.1 |
0.4 |
GO:0000451 |
rRNA 2'-O-methylation(GO:0000451) |
| 0.1 |
0.3 |
GO:0032455 |
nerve growth factor processing(GO:0032455) |
| 0.1 |
1.0 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 |
0.9 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.1 |
0.3 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 |
0.7 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
0.7 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
| 0.1 |
0.5 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.1 |
0.3 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.1 |
1.2 |
GO:0060850 |
regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.1 |
0.5 |
GO:0015692 |
lead ion transport(GO:0015692) |
| 0.1 |
1.9 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 |
0.4 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
0.9 |
GO:1901977 |
negative regulation of cell cycle checkpoint(GO:1901977) |
| 0.1 |
0.5 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 |
0.3 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.1 |
0.2 |
GO:0072717 |
cellular response to actinomycin D(GO:0072717) |
| 0.1 |
0.6 |
GO:0019418 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.1 |
0.3 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.1 |
0.3 |
GO:0051155 |
positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.1 |
0.3 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.1 |
0.3 |
GO:0098856 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.1 |
1.3 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
0.2 |
GO:1901895 |
negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.1 |
1.0 |
GO:2000257 |
regulation of protein activation cascade(GO:2000257) |
| 0.1 |
0.2 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.1 |
0.5 |
GO:0060445 |
branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.1 |
1.4 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.2 |
GO:0046813 |
receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.1 |
0.3 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
0.3 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.1 |
1.8 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 |
0.3 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
0.1 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.1 |
0.2 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.1 |
0.2 |
GO:1903352 |
L-ornithine transmembrane transport(GO:1903352) |
| 0.1 |
1.8 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.1 |
0.1 |
GO:0046878 |
positive regulation of saliva secretion(GO:0046878) |
| 0.1 |
0.3 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 |
2.2 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.1 |
GO:0008291 |
acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
| 0.1 |
1.7 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.1 |
0.7 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
0.3 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 |
0.2 |
GO:0033121 |
regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
| 0.1 |
0.5 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
0.2 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.1 |
0.7 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.7 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
0.9 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.2 |
GO:0015842 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.1 |
0.2 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.1 |
0.3 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.1 |
0.3 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.1 |
0.4 |
GO:1904744 |
positive regulation of telomeric DNA binding(GO:1904744) |
| 0.1 |
0.3 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
0.3 |
GO:0051037 |
regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.1 |
0.2 |
GO:0070054 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) protein trans-autophosphorylation(GO:0036290) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) peptidyl-serine trans-autophosphorylation(GO:1990579) |
| 0.1 |
0.1 |
GO:0035482 |
gastric motility(GO:0035482) gastric emptying(GO:0035483) |
| 0.1 |
0.9 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 |
0.1 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
0.5 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
1.0 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.1 |
0.2 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.1 |
3.1 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.1 |
1.9 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.2 |
GO:2001200 |
positive regulation of dendritic cell differentiation(GO:2001200) |
| 0.1 |
0.4 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.7 |
GO:0001712 |
ectodermal cell fate commitment(GO:0001712) |
| 0.1 |
0.9 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.1 |
0.2 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.1 |
0.2 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.1 |
1.5 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 |
0.5 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.1 |
1.5 |
GO:2000647 |
negative regulation of stem cell proliferation(GO:2000647) |
| 0.1 |
1.8 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.1 |
0.8 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.1 |
0.2 |
GO:0002913 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.1 |
4.7 |
GO:0032233 |
positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.1 |
0.1 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 |
1.2 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 |
0.7 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 |
0.2 |
GO:0061589 |
calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 |
0.5 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.1 |
0.1 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.1 |
0.2 |
GO:0051695 |
actin filament uncapping(GO:0051695) |
| 0.1 |
0.7 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 |
2.7 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
0.7 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
0.3 |
GO:0048200 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 |
0.2 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
0.2 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.1 |
0.5 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 |
1.6 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.1 |
0.7 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.1 |
0.7 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.1 |
GO:2001279 |
regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.1 |
0.4 |
GO:0001765 |
membrane raft assembly(GO:0001765) |
| 0.1 |
0.8 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.7 |
GO:0019720 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 |
0.4 |
GO:0090156 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 |
0.4 |
GO:0072366 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.1 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.2 |
GO:0071675 |
mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.1 |
0.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.2 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.1 |
0.9 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.1 |
0.4 |
GO:0060751 |
branch elongation involved in mammary gland duct branching(GO:0060751) |
| 0.1 |
0.6 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 |
0.4 |
GO:0035511 |
oxidative DNA demethylation(GO:0035511) |
| 0.1 |
0.6 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.1 |
0.6 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.1 |
GO:1905063 |
regulation of vascular smooth muscle cell differentiation(GO:1905063) |
| 0.1 |
1.1 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
1.1 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 |
0.1 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.1 |
1.2 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 |
0.9 |
GO:0070233 |
negative regulation of T cell apoptotic process(GO:0070233) |
| 0.1 |
0.4 |
GO:0015691 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 |
0.5 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.1 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 0.1 |
0.3 |
GO:2000314 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 |
0.6 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
0.1 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 |
0.4 |
GO:1904222 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.8 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 |
1.6 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) |
| 0.1 |
1.0 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.1 |
0.2 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
1.2 |
GO:0042481 |
regulation of odontogenesis(GO:0042481) |
| 0.1 |
0.1 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.1 |
0.1 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 |
0.3 |
GO:2000234 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 |
3.7 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.1 |
0.2 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 |
0.3 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.1 |
0.5 |
GO:0051195 |
negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.1 |
2.2 |
GO:0001570 |
vasculogenesis(GO:0001570) |
| 0.1 |
0.1 |
GO:0070873 |
regulation of glycogen metabolic process(GO:0070873) |
| 0.1 |
0.2 |
GO:0051919 |
positive regulation of fibrinolysis(GO:0051919) |
| 0.1 |
0.4 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.1 |
0.3 |
GO:0019064 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 |
0.2 |
GO:0036245 |
cellular response to menadione(GO:0036245) |
| 0.1 |
0.4 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.1 |
0.5 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
| 0.1 |
0.1 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.1 |
0.1 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
| 0.1 |
1.1 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.1 |
0.1 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 0.1 |
0.7 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 |
0.3 |
GO:0051124 |
synaptic growth at neuromuscular junction(GO:0051124) |
| 0.1 |
0.4 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.1 |
0.7 |
GO:0060972 |
left/right pattern formation(GO:0060972) |
| 0.1 |
1.9 |
GO:0050427 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 |
0.1 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.1 |
GO:0044571 |
[2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 |
0.5 |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.1 |
1.0 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 |
0.4 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
1.0 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 |
1.1 |
GO:0002192 |
IRES-dependent translational initiation(GO:0002192) |
| 0.1 |
1.2 |
GO:0014889 |
muscle atrophy(GO:0014889) |
| 0.1 |
0.1 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.1 |
1.0 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.5 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 |
0.6 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.1 |
0.2 |
GO:0071962 |
mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.1 |
0.6 |
GO:0090190 |
positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.1 |
0.2 |
GO:2000836 |
androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
| 0.1 |
0.4 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.1 |
0.3 |
GO:0051138 |
positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 |
0.2 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.1 |
2.4 |
GO:0030239 |
myofibril assembly(GO:0030239) |
| 0.1 |
1.3 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 |
0.1 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.1 |
0.2 |
GO:0019441 |
tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.1 |
0.4 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.1 |
0.1 |
GO:0009447 |
putrescine catabolic process(GO:0009447) |
| 0.1 |
0.4 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.1 |
0.2 |
GO:0033383 |
geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.1 |
0.3 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.1 |
0.4 |
GO:2000984 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.1 |
0.1 |
GO:0051307 |
meiotic chromosome separation(GO:0051307) |
| 0.1 |
0.2 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.1 |
0.2 |
GO:1902081 |
regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.1 |
0.3 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.1 |
0.3 |
GO:0009440 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.1 |
0.4 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
0.2 |
GO:0015847 |
putrescine transport(GO:0015847) |
| 0.1 |
0.5 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
0.7 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
0.1 |
GO:1901724 |
positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.1 |
0.1 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.1 |
0.1 |
GO:0015860 |
purine nucleoside transmembrane transport(GO:0015860) |
| 0.1 |
1.3 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
0.1 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.1 |
2.3 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.1 |
0.9 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.1 |
0.1 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 |
0.2 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.1 |
0.2 |
GO:0006286 |
base-excision repair, base-free sugar-phosphate removal(GO:0006286) telomere maintenance via base-excision repair(GO:0097698) |
| 0.1 |
0.2 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 |
0.2 |
GO:0035509 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.1 |
0.3 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 |
0.4 |
GO:0070120 |
ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.1 |
0.9 |
GO:0070197 |
meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.1 |
1.0 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 |
0.1 |
GO:0036514 |
dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
| 0.1 |
0.3 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
0.3 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.1 |
1.3 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 |
1.0 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.1 |
0.2 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.1 |
0.3 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.1 |
GO:0006565 |
L-serine catabolic process(GO:0006565) |
| 0.1 |
0.2 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.1 |
0.1 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.1 |
1.4 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.1 |
0.2 |
GO:2000105 |
positive regulation of DNA-dependent DNA replication(GO:2000105) |
| 0.1 |
0.7 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 |
0.2 |
GO:0018160 |
peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 0.1 |
0.2 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.1 |
0.1 |
GO:0035962 |
response to interleukin-13(GO:0035962) |
| 0.1 |
0.2 |
GO:0051547 |
regulation of keratinocyte migration(GO:0051547) |
| 0.1 |
5.0 |
GO:0006805 |
xenobiotic metabolic process(GO:0006805) |
| 0.1 |
0.3 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.1 |
0.2 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
0.3 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 |
0.2 |
GO:1901073 |
N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.1 |
0.1 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.1 |
3.6 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
| 0.1 |
1.1 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.2 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 |
0.6 |
GO:0010623 |
programmed cell death involved in cell development(GO:0010623) |
| 0.1 |
0.9 |
GO:0070328 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.1 |
0.2 |
GO:0060872 |
semicircular canal development(GO:0060872) |
| 0.1 |
0.3 |
GO:0035924 |
cellular response to vascular endothelial growth factor stimulus(GO:0035924) |
| 0.1 |
3.3 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.1 |
0.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.3 |
GO:0009093 |
cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.1 |
0.2 |
GO:0070476 |
RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.1 |
0.5 |
GO:0017182 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 |
0.2 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.1 |
0.2 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 0.1 |
0.1 |
GO:0034699 |
response to luteinizing hormone(GO:0034699) |
| 0.1 |
0.6 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.1 |
0.1 |
GO:0002316 |
follicular B cell differentiation(GO:0002316) |
| 0.1 |
0.8 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.1 |
0.6 |
GO:0030511 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.1 |
0.1 |
GO:0003095 |
pressure natriuresis(GO:0003095) |
| 0.1 |
2.5 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.1 |
0.3 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 |
0.2 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
5.7 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
2.0 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
0.5 |
GO:0021997 |
neural plate axis specification(GO:0021997) |
| 0.1 |
0.2 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.0 |
0.2 |
GO:0033132 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.2 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.0 |
0.1 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
| 0.0 |
0.3 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.0 |
0.1 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.0 |
0.1 |
GO:0050955 |
thermoception(GO:0050955) |
| 0.0 |
0.5 |
GO:0060005 |
vestibular reflex(GO:0060005) |
| 0.0 |
0.2 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.0 |
0.9 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.0 |
0.9 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.1 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.0 |
0.9 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.1 |
GO:0017185 |
peptidyl-lysine hydroxylation(GO:0017185) |
| 0.0 |
0.2 |
GO:0085032 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.0 |
1.0 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.0 |
0.2 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.0 |
0.0 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
| 0.0 |
3.5 |
GO:0098869 |
cellular oxidant detoxification(GO:0098869) |
| 0.0 |
0.1 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.0 |
0.6 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.2 |
GO:1904383 |
response to sodium phosphate(GO:1904383) |
| 0.0 |
0.4 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.0 |
0.2 |
GO:0035750 |
protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.0 |
1.0 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 |
0.5 |
GO:0001996 |
positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
| 0.0 |
0.4 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
1.6 |
GO:0050918 |
positive chemotaxis(GO:0050918) |
| 0.0 |
0.0 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.0 |
0.2 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.0 |
0.3 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.0 |
0.1 |
GO:0046041 |
ITP metabolic process(GO:0046041) |
| 0.0 |
0.3 |
GO:0072733 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 |
0.2 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.0 |
0.2 |
GO:0045047 |
protein targeting to ER(GO:0045047) |
| 0.0 |
0.1 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.0 |
0.5 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.2 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.0 |
0.5 |
GO:0007567 |
parturition(GO:0007567) |
| 0.0 |
0.1 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.3 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.0 |
0.3 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.0 |
1.4 |
GO:0003151 |
outflow tract morphogenesis(GO:0003151) |
| 0.0 |
0.3 |
GO:1900004 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 |
0.2 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 0.0 |
0.3 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 |
0.3 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.0 |
0.5 |
GO:0048566 |
embryonic digestive tract development(GO:0048566) |
| 0.0 |
0.8 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
4.0 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.0 |
0.2 |
GO:0046622 |
positive regulation of organ growth(GO:0046622) |
| 0.0 |
1.4 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.0 |
1.2 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 0.0 |
0.2 |
GO:0044789 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.0 |
0.5 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.1 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.0 |
0.6 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.2 |
GO:0033387 |
putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.0 |
0.2 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.0 |
0.3 |
GO:0043032 |
positive regulation of macrophage activation(GO:0043032) |
| 0.0 |
0.0 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.0 |
0.1 |
GO:0045655 |
regulation of monocyte differentiation(GO:0045655) |
| 0.0 |
0.3 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.2 |
GO:0044376 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 |
0.7 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.1 |
GO:0061187 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.0 |
0.4 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
0.3 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.0 |
0.3 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.0 |
0.2 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.0 |
0.3 |
GO:0042448 |
progesterone metabolic process(GO:0042448) |
| 0.0 |
0.2 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.0 |
0.0 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.0 |
0.1 |
GO:0035397 |
helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.0 |
0.3 |
GO:0032485 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 |
0.3 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 |
0.3 |
GO:0017062 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 0.0 |
0.1 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.0 |
0.2 |
GO:0033489 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.0 |
0.2 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 |
0.3 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.0 |
0.2 |
GO:0009253 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.0 |
0.3 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 |
0.0 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.0 |
0.4 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.0 |
0.1 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.0 |
0.1 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.0 |
0.5 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.0 |
GO:0097198 |
histone H3-K36 trimethylation(GO:0097198) |
| 0.0 |
0.4 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 |
0.1 |
GO:1905244 |
regulation of modification of synaptic structure(GO:1905244) |
| 0.0 |
2.0 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.0 |
0.1 |
GO:0034441 |
plasma lipoprotein particle oxidation(GO:0034441) |
| 0.0 |
0.1 |
GO:0035864 |
response to potassium ion(GO:0035864) |
| 0.0 |
0.1 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.0 |
0.2 |
GO:0060512 |
prostate gland morphogenesis(GO:0060512) |
| 0.0 |
0.1 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.0 |
0.7 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 |
0.2 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.0 |
0.3 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.0 |
1.2 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 |
0.5 |
GO:0001845 |
phagolysosome assembly(GO:0001845) phagosome-lysosome fusion(GO:0090385) |
| 0.0 |
0.4 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
0.3 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 |
0.6 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.2 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 |
0.1 |
GO:1903445 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.0 |
0.5 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 |
0.2 |
GO:1905123 |
regulation of glucosylceramidase activity(GO:1905123) |
| 0.0 |
10.1 |
GO:0007517 |
muscle organ development(GO:0007517) |
| 0.0 |
0.7 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 |
0.2 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.0 |
0.3 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.0 |
0.2 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.0 |
0.2 |
GO:0090034 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.0 |
0.2 |
GO:0030210 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 |
0.1 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.0 |
0.4 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.0 |
0.1 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.0 |
0.0 |
GO:0097267 |
omega-hydroxylase P450 pathway(GO:0097267) |
| 0.0 |
0.4 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.2 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.2 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.0 |
0.2 |
GO:0048747 |
muscle fiber development(GO:0048747) |
| 0.0 |
0.3 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.0 |
0.1 |
GO:0002070 |
epithelial cell maturation(GO:0002070) |
| 0.0 |
1.8 |
GO:0051216 |
cartilage development(GO:0051216) |
| 0.0 |
0.1 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.0 |
0.2 |
GO:0033189 |
response to vitamin A(GO:0033189) |
| 0.0 |
0.6 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 |
0.2 |
GO:1900165 |
negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.0 |
0.3 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.0 |
0.1 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.0 |
0.1 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 0.0 |
0.1 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.0 |
0.4 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.1 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.2 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.0 |
0.0 |
GO:0071639 |
positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 0.0 |
0.4 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.0 |
0.0 |
GO:0003099 |
positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.0 |
0.2 |
GO:1905216 |
regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
| 0.0 |
0.2 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 |
0.8 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 |
0.2 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.0 |
0.6 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.1 |
GO:0061015 |
snRNA import into nucleus(GO:0061015) |
| 0.0 |
0.1 |
GO:0070981 |
L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.0 |
0.3 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.0 |
0.1 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.0 |
0.4 |
GO:1904776 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.0 |
0.1 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.1 |
GO:0006288 |
base-excision repair, DNA ligation(GO:0006288) |
| 0.0 |
0.1 |
GO:0072674 |
multinuclear osteoclast differentiation(GO:0072674) |
| 0.0 |
0.2 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.0 |
0.1 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.0 |
0.1 |
GO:0015766 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.0 |
0.1 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 |
0.1 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.0 |
0.3 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.0 |
0.1 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.1 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.0 |
1.2 |
GO:0051058 |
negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 |
0.2 |
GO:0032689 |
negative regulation of interferon-gamma production(GO:0032689) |
| 0.0 |
0.0 |
GO:0097476 |
spinal cord motor neuron migration(GO:0097476) |
| 0.0 |
0.1 |
GO:0035886 |
vascular smooth muscle cell differentiation(GO:0035886) |
| 0.0 |
0.1 |
GO:1903259 |
exon-exon junction complex disassembly(GO:1903259) |
| 0.0 |
0.3 |
GO:0045842 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.0 |
0.2 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.0 |
0.0 |
GO:0035112 |
genitalia morphogenesis(GO:0035112) |
| 0.0 |
0.1 |
GO:0036499 |
PERK-mediated unfolded protein response(GO:0036499) |
| 0.0 |
0.1 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 |
0.1 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
0.0 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.0 |
0.1 |
GO:1903526 |
negative regulation of membrane tubulation(GO:1903526) |
| 0.0 |
0.5 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
0.4 |
GO:0031076 |
embryonic camera-type eye development(GO:0031076) |
| 0.0 |
0.1 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.0 |
0.0 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.0 |
0.2 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.0 |
0.1 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.0 |
0.2 |
GO:0042983 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.0 |
0.0 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.0 |
0.0 |
GO:0002581 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.0 |
0.3 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 |
0.1 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.0 |
0.1 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.0 |
0.1 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.0 |
0.1 |
GO:1902594 |
viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
| 0.0 |
0.1 |
GO:1903020 |
positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.0 |
0.4 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.0 |
0.1 |
GO:0072530 |
purine-containing compound transmembrane transport(GO:0072530) |
| 0.0 |
0.1 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 |
0.1 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.1 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.0 |
0.1 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.1 |
GO:0090675 |
intermicrovillar adhesion(GO:0090675) |
| 0.0 |
0.0 |
GO:0097536 |
peripheral T cell tolerance induction(GO:0002458) tolerance induction dependent upon immune response(GO:0002461) peripheral tolerance induction(GO:0002465) thymus epithelium morphogenesis(GO:0097536) |
| 0.0 |
0.0 |
GO:0051799 |
negative regulation of hair follicle development(GO:0051799) |
| 0.0 |
0.0 |
GO:0034093 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.0 |
0.0 |
GO:0043605 |
cellular amide catabolic process(GO:0043605) |
| 0.0 |
0.0 |
GO:0021539 |
subthalamus development(GO:0021539) |
| 0.0 |
0.0 |
GO:0051450 |
myoblast proliferation(GO:0051450) |
| 0.0 |
0.1 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.0 |
0.0 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.0 |
0.1 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.0 |
0.2 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 |
0.1 |
GO:0002254 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.0 |
2.0 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.0 |
0.1 |
GO:1900239 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.0 |
0.2 |
GO:0021983 |
pituitary gland development(GO:0021983) |
| 0.0 |
0.1 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.0 |
0.2 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.0 |
0.1 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.0 |
0.6 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
| 0.0 |
0.1 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 |
0.2 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.0 |
0.1 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.0 |
0.1 |
GO:0071839 |
suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) cellular process regulating host cell cycle in response to virus(GO:0060154) apoptotic process in bone marrow(GO:0071839) |
| 0.0 |
0.4 |
GO:0071548 |
response to dexamethasone(GO:0071548) |
| 0.0 |
0.1 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.0 |
0.1 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.0 |
0.0 |
GO:0060701 |
negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.0 |
0.1 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 0.0 |
1.1 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.0 |
0.2 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 |
0.1 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.0 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.0 |
0.1 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.2 |
GO:0050850 |
positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.0 |
0.2 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.0 |
GO:0002468 |
dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.0 |
0.1 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 |
0.0 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.0 |
0.1 |
GO:0002644 |
negative regulation of tolerance induction(GO:0002644) |
| 0.0 |
0.0 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.0 |
0.3 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.0 |
0.4 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
0.0 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.0 |
0.0 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.0 |
0.2 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
| 0.0 |
0.1 |
GO:0044860 |
protein localization to plasma membrane raft(GO:0044860) |
| 0.0 |
0.3 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 |
0.9 |
GO:0031016 |
pancreas development(GO:0031016) |
| 0.0 |
0.6 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 |
0.2 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.0 |
0.1 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.0 |
0.1 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.0 |
0.1 |
GO:0000271 |
polysaccharide biosynthetic process(GO:0000271) |
| 0.0 |
0.0 |
GO:2000360 |
negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.0 |
0.4 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
0.2 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.0 |
0.1 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.0 |
0.1 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.0 |
0.1 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.0 |
0.2 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.1 |
GO:0036124 |
histone H3-K9 trimethylation(GO:0036124) |
| 0.0 |
0.1 |
GO:0060713 |
embryonic placenta morphogenesis(GO:0060669) labyrinthine layer morphogenesis(GO:0060713) |
| 0.0 |
0.3 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 |
0.0 |
GO:0038031 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 |
0.0 |
GO:0045229 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.0 |
0.1 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 |
0.1 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.0 |
0.1 |
GO:0045736 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.0 |
0.0 |
GO:0050923 |
regulation of negative chemotaxis(GO:0050923) |
| 0.0 |
0.7 |
GO:0030509 |
BMP signaling pathway(GO:0030509) |
| 0.0 |
0.2 |
GO:0006032 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.3 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 |
0.0 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.0 |
0.1 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.0 |
0.6 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.0 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.0 |
0.0 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
